APA (7th ed.) Citation

Tanaka, K. A., Henderson, R., Thangaraju, K., Morita, Y., Mazzeffi, M. A., Strauss, E., . . . Buehler, P. W. (2022). In vitro effects of emicizumab on activated clotting time in blood samples from cardiac surgical patients. Haemophilia, 28(1), 183. https://doi.org/10.1111/hae.14452

Chicago Style (17th ed.) Citation

Tanaka, Kenichi A., Reney Henderson, Kiruphagaran Thangaraju, Yoshihisa Morita, Michael A. Mazzeffi, Erik Strauss, Upendra Katneni, and Paul W. Buehler. "In Vitro Effects of Emicizumab on Activated Clotting Time in Blood Samples from Cardiac Surgical Patients." Haemophilia 28, no. 1 (2022): 183. https://doi.org/10.1111/hae.14452.

MLA (9th ed.) Citation

Tanaka, Kenichi A., et al. "In Vitro Effects of Emicizumab on Activated Clotting Time in Blood Samples from Cardiac Surgical Patients." Haemophilia, vol. 28, no. 1, 2022, p. 183, https://doi.org/10.1111/hae.14452.